When

Monday, November 12, 2018 at 8:00 AM EST
-to-
Tuesday, November 13, 2018 at 3:30 PM EST

Add to Calendar 

Where

DoubleTree by Hilton Hotel-Philadelphia Center City
237 S. Broad Street
Philadelphia, PA 19107

This conference has been confirmed. 



Driving Directions 

Contact

Mary Ellen Sutton 
The Microbiology Network/Pharmaceutical Microbiology Forum 
585-210-8336 
conference@microbiologynetwork.com 
Join My Mailing List

2018 PMF Fall Forum: Current Trends in Pharmaceutical Microbiology

We are very excited to announce this year's PMF Fall Forum, "Current Trends in Pharmaceutical Microbiology".  Leading industry experts will present and discuss topics relating to current regulatory, compendial and enforcement trends in Quality Control Microbiology.


Our industries, relying on compliance with current Good Manufacturing Practices, are subject to the ever-evolving continuum of our regulatory environment.  This conference will provide you with a perspective on several current trends relating to QC Microbiology.  We are privileged to have well-recognized industry Subject Matter Experts present their knowledge and experiences with tackling the challenges associated with these trends, ranging from QC Microbiology data integrity to historical and current regulatory enforcement actions relating to Burkholderia cepecia complex.  Effectively recognizing and addressing these current trends is key to cGMP compliance.

“Current Trends in Pharmaceutical Microbiology” will provide an excellent opportunity for participants to acquire the knowledge and learn the skills necessary for managing these challenges.

MAIN TOPICS
  • Utilizing an Organized Data Driven Approach to Investigate, Solve Problems, and Demonstrate Process Control
  • Establishing Environmental Monitoring Alert and Action Levels: A Novel Case Study
  • Burkholderia cepacia complex: Current Regulatory Trends
  • Manufacturing Quality Product in an Aging Facility
  • Monitoring of Purified Water Systems
  • QC Microbiology: How Automation and Integration Enforce Data Integrity
  • Use of the USP for Training, Standards, and Best Practices in Pharmaceutical Microbiology
  • Surviving the Microbiology Lab Audit - Tips from the Trenches
  • Identification Techniques of Environmental Isolates

WHO SHOULD ATTEND

  • Microbiology laboratory supervisors and microbiologists responsible for testing and release of Pharmaceutical, Biologic and Medical Device products
  • Regulatory and Quality compliance personnel responsible for auditing and ensuring GMP compliance of manufacturing facilities and microbiology laboratories, including contract manufacturers and laboratories
  • Manufacturing, Engineering and Validation personnel responsible for contributing to microbiology laboratory and QC Microbiology GMP operations
  • GMP trainers   

 

Our industries, relying on compliance with current Good Manufacturing Practices, are subject to the ever-evolving continuum of our regulatory environment.  This conference will provide you with a perspective on several current trends relating to QC Microbiology.  We are privileged to have well-recognized industry Subject Matter Experts present their knowledge and experiences with tackling the challenges associated with these trends, ranging from QC Microbiology data integrity to historical and current regulatory enforcement actions relating to Burkholderia cepecia complex.  Effectively recognizing and addressing these current trends is key to cGMP compliance. 

Early Registration Discount: Register by October 5th to receive $200 off the registration fee!

TRAVEL INFORMATION:

Nearest Airport:  PHL

Register Now! 

Cancellation Policy: PMF and Microbiology Network reserve the right to modify or cancel any event.  In the event of a cancellation, registrants will be notified as soon as possible and all registration fees will be reimbursed.  PMF and Microbiology Network are not responsibile for lost airfare due to cancellations.  Refund requests received at least 14 days prior to the date of the event will receive a full refund, less a $200 processing fee.  After that, no refunds will be issued.You may enroll a substitute at any time before the conference begins.

Schedule

Monday, November 12, 2018

8:00 - 8:30 am

Registration and Full Breakfast Buffet 

8:30 - 9:00 am

Welcome –  Robert Westney

9:00 - 10:30 am

Utilizing an Organized Data Driven Approach to Investigate, Solve Problems, and Demonstrate Process Control – Matthew Paquette, Product Specialist, Charles River

10:30 - 11:00 am

Break 

11:00 am - 12:00 pm

Establishing Environmental Monitoring Alert and Action Levels: A Novel Case Study – Doug Schmidt, Director of Quality Control, Exela Pharma Sciences LLC

12:00 - 1:00 pm

LUNCH 

1:00 - 2:00 pm

Burkholderia cepacia complex: Current Regulatory Trends – Robert Westney, Director of Quality and Operations, Cryologics Inc.

2:00 - 3:00 pm

Manufacturing Quality Product in an Aging Facility – Randy Hutt, Associate Director, Microbiological Services, Luitpold Pharmaceuticals 

3:00 – 3:30 pm

BREAK

3:30 - 5:00 pm

Monitoring of Purified Water Systems – Tony Cundell, Ph.D., Consulting Microbiologist

5:00 - 6:30 pm

RECEPTION 

 

Tuesday, November 13, 2018

8:00 - 8:30 am

Registration and Full Breakfast Buffet 

8:30 - 10:00 am

QC Microbiology: How Automation and Integration Enforce Data Integrity – Rob Lutskus, Global Product Delivery Manager – Informatics, Lonza

10:00 - 10:30 am

BREAK 

10:30 - 11:30 am

Use of the USP for Training, Standards, and Best Practices in Pharmaceutical Microbiology – Don Singer, Senior Fellow, Microbiology, Biopharmaceutical GMP Operations, GlaxoSmithKline

11:30 am -12:30 pm

LUNCH 

12:30 - 1:30 pm

Surviving the Microbiology Lab Audit - Tips from the Trenches – Rick Jakober, Vice President of Laboratory Services, Perritt Laboratories, Inc.

1:30 - 2:00 pm

BREAK 

2:00 - 3:00 pm

Identification Techniques of Environmental Isolates – Brian Beck, Ph.D., VP of Research and Development, Microbiologics Inc. 

3:00 - 3:30 pm

Panel Discussion

  • Robert Westney
  • Matthew Paquette
  • Doug Schmidt
  • Tony Cundell
  • Randy Hutt
  • Rob Lutskus
  • Don Singer
  • Rick Jakober
  • Brian Beck

3:30

Conference Concludes


Speakers

Robert Westney, Moderator 

Bob is the Founder and President of Cryologics Inc., Principal Consultant for Westney & Associates Consulting LLC, and a member of the Microbiology Network consortium of consultants.  He has more than 30 years of experience in the GMP industry, including Quality Control Microbiology, Quality Assurance and Regulatory Affairs.  He holds a Master of Science degree from Temple University in Quality Assurance / Regulatory Affairs.  He is Regulatory Affairs Certified (RAC) and is a Certified Manager of Quality and Organizational Excellence (CMQ / OE).  He is a member of the Pharmaceutical Microbiology Forum (PMF), the American Society for Microbiology (ASM), the Parenteral Drug Association (PDA), the Regulatory Affairs Professional Society (RAPS), and a Senior Member of the American Society for Quality (ASQ).

Matthew Paquette 

Matthew Paquette is a Product Specialist for Charles River.  He received his Bachelor of Science degree in microbiology from the University of Massachusetts Amherst and his Master of Business Administration degree in Six Sigma / Quality Management from Southern New Hampshire University. Matthew has over 10 years of experience in Quality Control Microbiology, Regulatory Compliance, Pharmaceutical Investigations, and Manufacturing Science. His other industry experience includes utilizing Six Sigma and DMAIC methodologies to drive to root cause of complex quality control and manufacturing problems, leading cross-functional investigation teams, leading method development and validation teams in the quality control microbiology laboratory space, and leading beta testing teams for new and complex laboratory instrumentation. 

Doug Schmidt  

Doug Schmidt is the Director of Quality Control for Exela Pharma Sciences overseeing QC Microbiology and QC Chemistry laboratory operations. He has worked in sterile pharmaceutical manufacturing for the past 10 years and in GMP pharmaceutical manufacturing for 15 years with QC Microbiology experience in both sterile and non-sterile processes. Doug holds a B.S. degree from Clemson University in Microbiology. He is a member of the Pharmaceutical Microbiology Forum (PMF), the American Society for Microbiology (ASM), and the Parenteral Drug Association (PDA).  

Tony Cundell  

Dr. Tony Cundell consults with a number of pharmaceutical, consumer health and dietary supplement companies, microbiology instrument manufacturers, contract testing laboratories and sterile compounding pharmacies in the areas of microbial risk assessment, regulatory affairs, and microbiological testing. Prior to November 2013 he held high-level positions at Merck Research Laboratories, New York Blood Center, Lederle Laboratories, Wyeth Pharmaceuticals and Schering-Plough. Tony is a member of the 2015-2020 USP Microbiology Committee of Experts.  He is very involved with the Parenteral Drug Association, having played key roles in developing PDA Technical Reports No. 33 and 67. He has authored numerous book chapters and industry publications.  More recently Tony Cundell co-authored a review article entitled “Data Integrity in the Microbial Testing” in the September-October, 2017 issue of American Pharmaceutical Review.

Randy Hutt  

Dr. Randy Hutt has over 35 years of experience in the Pharmaceutical and Biological industries, Quality Control and Quality Assurance management in pharmaceutical companies such as Luitpold Pharmaceuticals (LPI), Schering Plough, Burroughs Wellcome and Wyeth-Lederle.  Currently, Dr. Hutt is an advisor to the VP of Quality at Luitpold Pharmaceuticals (LPI) as Associate Director of Microbiological Services, completing project work and providing technical expertise.  She continues to be involved with training, harmonization of procedures between different sites, and respond to inquiries from R&D. In addition, she is Head of the Sterility Assurance Group.  Her experience includes several years of consulting, both in the US and internationally, performing pharmaceutical microbiological Investigations, cGMP audits, and training on how to perform audits.  She has given presentations on Microbial Investigations to the Parenteral Drug Association (PDA), the Pharmaceutical Microbiology Forum (PMF) and the Institute of Validation Technology (IVT). . 

 

Rob Lutskus 

Rob Lutskus is a subject matter expert on laboratory informatics within quality control for the bio-pharmaceutical industry. Currently, Associate Director, Commercial Operations for Lonza Bioscience Informatics, with whom he joined in 2007, Rob is responsible for leading all customer service, support and professional delivery activities for Lonza's Informatics software portfolio.  He also develops the product strategy and roadmap for software releases. Rob has worked in QC laboratories and Laboratory Informatics for over 15 years.  Originally a QC microbiologist, Rob has worked for Merck, Hoffman La Roche and Baxter before joining ImClone Systems in Branchburg, NJ.  He is an active member in a variety of industry organizations, including the Parenteral Drug Association and ISPE.
Presentation Topic: QC Microbiology: How Automation and Integration Enforce Data Integrity

Don Singer 

Don Singer is a GSK Senior Fellow, an American Society for Quality Fellow and Manager, Steriles Microbiology-GMP Ops at GSK.  Don has been a member of the USP Microbiology Committee of Experts since 2000.  He is a Certified Specialist Microbiologist (NRCM) and Certified Pharmaceutical GMP Professional (ASQ), and has been a Malcolm Baldrige National Quality Award Examiner. Don’s career spans over 40 years of research, Quality Control and Quality Assurance experience in the pharmaceutical, cosmetic, and food industries.  He is also currently an adjunct instructor in the Biopharmaceutical Quality program at University of Maryland Baltimore County.

Rick Jakober 

Rick Jakober is the Vice President, Laboratory Services, at Perritt Laboratories, Inc.  He earned a B.S. in Environmental Sciences at Cook College, Rutgers University. Rick is a seasoned researcher with wide ranging experience in microbiological analyses including in-depth knowledge of FDA and compendial cGMP requirements combined with broad knowledge and experience in USP, Ph. Eur., JP, ISO, ASTM, EPA, and AOAC methodologies. In addition, he has over 35 years of experience in pharmaceutical microbiology, specializing in non-sterile products. This includes Microbial Content testing, Antimicrobial Effectiveness Testing, Purified Water Systems, Environmental Monitoring, Mycology and inorganic chemical analyses.  Rick has been with Perritt Laboratories since 1987 and previously was with Carter-Wallace and Ayerst Laboratories.

Brian Beck 

Brian Beck is the Vice President of Research and Development for Microbiologics and has led the organization’s molecular products and services division since 2013. Brian leads technology assessment activities focused on quantitation, inactivation, and preservation of microorganisms for novel, ready-to-use formats. He works closely with Microbiologics’ molecular diagnostic development partners to customize controls used in development, regulatory assessment and verification and validation activities. Before joining Microbiologics, Brian managed the Microbiology Collections at ATCC where he led efforts to acquire and authenticate type cultures and emerging pathogens for the research community. Brian earned his Ph.D. in Bacteriology from the University of Wisconsin-Madison and completed research appointments at the University of Minnesota and the University of Michigan.